Ocugen Doses First Patient in Phase 2/3 GARDian3 T...
Category : Clinical Trial Update 23 July 2025Ocugen Inc, a biotech innovator in gene therapies for blindness, has announced a major milestone&mda...
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Ocugen Inc, a biotech innovator in gene therapies for blindness, has announced a major milestone&mda...
Overview Sun Pharmaceutical Industries Limited announced top-line results from two phase 3 clinic...
Overview Keros Therapeutics, Inc. (Keros), a clinical-stage biopharmaceutical company, announced...
Overview AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (collectively AusperBio), a...
Overview The US Food and Drug Administration (FDA) announced it has placed Sarepta Therapeutics i...